The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mehta Vimal since year 2005.
The trader's CIK number is 1733369.
At the time of the last reporting, Mehta Vimal was the CEO, President, Secretary of Bioxcel Therapeutics, Inc. .
(stock ticker symbol BTAI).
See this page for all insider trading activities at Bioxcel Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-14||BTAI||Bioxcel Therapeutics, Inc.||Buy||2,000||4.41||8,824|
|2018-12-03||BTAI||Bioxcel Therapeutics, Inc.||Buy||1,000||5.15||5,150|
|2018-12-04||BTAI||Bioxcel Therapeutics, Inc.||Buy||1,000||5.12||5,120|
|2018-11-30||BTAI||Bioxcel Therapeutics, Inc.||Buy||1,000||5.12||5,115|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mehta Vimal (CEO, President, Secretary of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.